Robitussin pulled from shelves due to microbial contamination

U.S. Food and Drug Administration

The FDA says some effected bottles have expiration dates up to two years away

Two types of Robitussin cough syrups are being pulled from shelves due to microbial contamination: Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult. 

Haleon, the company that produces Robitussin, has voluntarily decided to recall the contaminated bottles from stores in an effort to keep consumers safe and healthy. According to the U.S. Food and Drug Administration (FDA), the biggest risk is posed to those with compromised immune systems. 

“In immunocompromised individuals, the use of the affected product could potentially result in severe or life-threatening adverse events such as fungemia or disseminated fungal infection,” the FDA wrote

Fungemia is when fungus or yeast has entered the bloodstream, and may be associated with sepsis in some cases. A disseminated fungal infection is when the infection spreads to other parts of the body, including bone lesions, ulcers, meningitis, heart inflammation, and more. Both instances can be life-threatening to those with compromised immune systems. 

It’s important to note that all consumers are susceptible to an infection from consuming contaminated lots of Robitussin. The FDA says that consumers should contact their doctors if they experience any issues related to the medication. 

What to avoid

Of the two types of Robitussin that have been identified as having microbial contamination, Haleon has recalled eight different lots of the medication. These include: 

  • Robitussin Honey CF Max Day Adult 4oz.

    • Lot #: T10810

    • Expiration Date: October 31, 2025

  • Robitussin Honey CF Max Day Adult 8oz. 

    • Lot #: T08730; T08731; T08732; T08733; T10808

    • Expiration Date: May 31, 2025 and September 30, 2025

  • Robitussin Honey CF Max Nighttime Adult 8oz. 

    • Lot#: T08740; T08742

    • Expiration Date: June 30, 2026

As of right now, there have been no reports of any infection or other adverse events related to this medication. However, the FDA urges consumers to check their medicine cabinets immediately and throw away any potentially contaminated bottles of cough syrup. 

Retailers and other distributors of the affected bunches of Robitussin have been notified of the contamination, and consumers can report their experience with the product to the FDA’s MedWatch Adverse Event Reporting Program here

Find a Solar Energy partner near you.